WideCells Group PLC (LON:WDC), the stem cell services and stem cell-related insurance specialist, said its 2017 financial statements are nearing completion.
The additional time required to finalise the results mean its live bookbuild via the Teathers mobile app has been extended until the figures are released.
READ: WideCells unveils fund-raising details
In the same market update, Widecells said it is in discussions with the Financial Conduct Authority to lift the share suspension once its numbers have been filed.
"The company will update the market in due course," it added.